FIELD: medicine.
SUBSTANCE: invention refers to biotechnology, particularly concerns a vaccine preparation which can be used for controlling viral and other diseases of infectious nature. A reaction product of cationic oligomer and antigen determinant in an equimolar amount are used as an antigen polypeptide.
EFFECT: preparation exhibits improved immunogenic properties.
2 dwg, 5 ex
Title | Year | Author | Number |
---|---|---|---|
BIOLOGICALLY ACTIVE COMPLEX EXHIBITING INFLUENZA VIRUS PROTECTIVE ACTIVITY | 2009 |
|
RU2427385C1 |
METHOD OF PREPARING BIOLOGICALLY ACTIVE COMPLEX | 2009 |
|
RU2427386C1 |
IMMUNOGENIC COMPOSITION, CONTAINING FOREIGN ANTIGENS ON SURFACE OF SPHERICAL CARRIERS, OBTAINED BY THERMAL DENATURATION OF SPIRAL VIRUSES | 2010 |
|
RU2440140C1 |
THE METHOD OF IMMUNE RESPONSE ENHANCEMENT | 2010 |
|
RU2442604C1 |
NEW TYPE OF CARRIER PARTICLES (PLATFORMS) FOR PRODUCTION OF ACTIVE COMPLEXES | 2010 |
|
RU2441667C1 |
RECOMBINANT PLASMID DNA PTBI-HBSAG COMPRISING CHIMERIC GENE TBI-HBSAG UNDER CONTROL OF SMALLPOX VACCINE PROMOTER P7,5K AND STRAIN OF RECOMBINANT SMALLPOX VACCINE INDUCING IMMUNE RESPONSE AGAINST HIV AND HUMAN HEPATITIS B IN ANIMAL BODY | 2001 |
|
RU2194075C2 |
UNIVERSAL AVIAN INFLUENZA VIRUS VACCINE | 2007 |
|
RU2358981C2 |
RUBELLA VACCINE ON THE BASIS OF A STRUCTURALLY-MODIFIED VIRUS OF PLANTS AND A METHOD FOR ITS PRODUCTION | 2016 |
|
RU2660563C2 |
RECOMBINANT SWINE INFLUENZA VIRUS H1N1 VACCINE AND METHOD FOR PREPARING IT | 2010 |
|
RU2451027C2 |
VACCINE AGAINST HIV/AIDS | 2010 |
|
RU2475264C2 |
Authors
Dates
2011-01-20—Published
2009-09-09—Filed